The short version
- The Pharmacy First scheme now includes migraines, acne, scabies, ear infections, and blocked noses, bringing the total number of treatable conditions to twelve.
- NHS officials cite record emergency department activity and long wait times for routine appointments as primary drivers for expanding community-based care options.
- Pharmacy industry leaders warn that current government funding levels may be insufficient to support the increased workload associated with these new prescribing responsibilities.
Patients in England will gain access to on-the-spot treatment for five additional common health conditions through local pharmacies this autumn, marking a significant expansion of community-based healthcare services. The initiative allows individuals to receive prescriptions for migraines, acne, scabies, ear infections, and severely blocked noses without first consulting a general practitioner. This development builds upon an existing framework that already permits pharmacists to prescribe medication for seven other ailments, including sore throats, sinusitis, shingles, impetigo, infected bites, and urinary tract infections.
The expansion is part of a broader strategy by NHS England to alleviate intense pressure on primary care networks and accident and emergency departments. Following a particularly hot summer and three consecutive months of record-high activity in A&E units across the country, health officials are prioritizing convenient and rapid access to treatment for everyday medical issues. The goal is to divert patients with minor conditions away from overcrowded hospitals and busy GP surgeries, ensuring that urgent cases receive appropriate attention while routine matters are handled closer to home.
Prime Minister Andy Burnham emphasized the practical benefits of this shift, noting that many citizens have grown frustrated with the difficulty of securing routine medical appointments. He argued that allowing people to walk into a local pharmacy for immediate care would save families valuable time and reduce the need to take leave from work. By treating these conditions locally, the government hopes to streamline the patient journey and improve overall satisfaction with the healthcare system.
The rollout will begin gradually, with only a few hundred chemists initially offering treatments for the five new conditions. Over time, the service is expected to expand to thousands of community NHS pharmacies throughout England. Patients can access these services by walking directly into a participating pharmacy, being referred by their GP, or receiving a referral through the NHS111 helpline. This flexible approach aims to maximize accessibility and ensure that individuals can obtain help when they need it most.
Since its inception in 2024, the Pharmacy First scheme has facilitated approximately 14 million consultations. Data indicates that two million of these appointments were for sore throats, while 1.7 million addressed urinary tract infections. These figures suggest a high level of engagement with the service and demonstrate the potential for pharmacies to handle a significant volume of primary care needs. The success of these initial conditions has likely informed the decision to broaden the scope of treatable ailments.
Supporters of the expansion view it as a positive step toward improving patient care pathways. Rob Music, chief executive of the Migraine Trust, expressed delight at the inclusion of migraines in the program, describing it as a wonderful opportunity for faster and improved care. Dr. Amanda Doyle, director for primary care and community services at NHS England, echoed this sentiment, stating that increased support in communities helps prevent unnecessary hospital admissions. Community pharmacies already provide various health services, including vaccinations, blood pressure monitoring, smoking cessation support, and advice on healthy living.
Despite the enthusiasm from health officials and patient advocacy groups, pharmacy industry representatives have raised concerns about financial sustainability. Henry Gregg, chief executive of the National Pharmacy Association, highlighted that pharmacies continue to face significant financial pressures. He argued that the current funding provided by the government does not adequately cover the workload associated with these new responsibilities. Industry leaders are calling for greater investment in the pharmacy network to ensure it can effectively transform the experience of everyday health issues without compromising service quality.
The model for England’s Pharmacy First scheme was inspired by similar initiatives in Scotland, where patients can be treated for 27 different conditions at chemists. Northern Ireland and Wales also have systems that allow pharmacies to treat patients with certain ailments. As England expands its own program, it will likely continue to draw lessons from these devolved administrations. The gradual rollout allows policymakers to monitor the impact of the new treatments on both patient outcomes and pharmacy operations before committing to a full-scale implementation across the country.
Sources behind this briefing
Go to the original reporting
- BBC News↗Migraines and acne among five more conditions pharmacists can treat
